In the UK, the COSHH Regulations give specific guidance that employers have duties to inform, instruct and train their employees about occupational risks and provide them with suitable health surveillance. The aim of the study was to evaluate the impact of the Regulations on employees with occupational asthma. One hundred consecutive patients attending an occupational lung disease clinic completed a questionnaire assessing the implementation of the COSHH Regulations in their workplace. Twenty-eight per cent had a pre-employment inquiry about asthma, 31% had regular health surveillance by questionnaires and 19% had regular lung function assessment at work. Pre-employment spirometry was carried out in 44% of the workers who were exposed to one of the original seven prescribed agents, significantly more than those who were exposed to other agents (19%) (p < 0.05). Moreover, figures for spirometry during employment were 31% and 8% respectively (p < 0.05). The patients who worked after 'COSHH' but before 'MS25' had a tendency to be provided with health surveillance more than those who worked after both 'COSHH' and 'MS25'. Ninety-one per cent of the patients had never been informed about the risks of getting asthma at work and 73% had never seen the safety data sheets. The workers who (1) worked after 'COSHH' introduction; (2) worked in larger firms and (3) were exposed to one of the original seven prescribed agents, had a tendency to be informed, instructed and trained more than the rest. However, there were only significant statistical differences (p < 0.05) in terms of the safety data sheet provision between the cases who worked before the time of the legislation and those employed afterwards.
INTRODUCTION
The Control of Substances Hazardous to Health (COSHH) Regulations have applied to all workplaces where people are exposed, or are liable to be exposed, to substances hazardous to health since October 1989.' They are based on the EC Chemical, Physical & Biological Agents at Work Directive 80/1107. The regulations require all employers to provide appropriate preventive or control measures to protect their employees' health. These include the provision of health and safety education, training and health surveillance.
Regarding occupational asthma, the Health and Safety Executive had prepared the medical guidance note, called MS25, for prevention of the disease since December 1991. 2 It recommends monitoring workers' health by health surveillance. The surveillance can be classified into three categories: low, intermediate and high levels. The selection of the suitable level depends on the nature of substances of which workers are exposed and the assessed risk.
There is no evidence that the incidence of occupational asthma has declined since 1989.
"
8 This may be due to poor compliance with the regulations. The HSE's evaluation survey in 1991/92 showed that COSHH had succeeded in enhancing many employers awareness of health risks in the workplace but small firms in particular were less compliant with the Regulations. 9 One study also showed poor compliance among hairdressers in terms of health and safety training.
ance with the Regulations, particularly the provision of instruction, training and health surveillance in workers who developed occupational asthma.
METHODS
One hundred consecutive patients with occupational asthma seen at a specialist occupational lung disease clinic in 1995 were the sample. They completed an interviewer-administered questionnaire which included details of their workplace and occupational health service provision, together with personal details and the date of diagnosis of occupational asthma. Specific enquiry about access to the Safety Data Sheets, risk information, control strategy and training were made. Details of pre-employment screening and periodic health surveillance were recorded. The sample was divided into those diagnosed before the introduction of 'COSHH', after 'COSHH' but before the introduction of 'MS25' and after 'MS25'; those from workplaces with more or less than 50 employees; and those who were exposed to one of the first seven agents recognized for compensation by the DSS or to other causes. 11 To identify the frequency and proportion of the variables, all data were analyzed by the computer • package program, Epi-info version 6. The data were analyzed to find the relationship between three independent variables {e.g. time of Regulations enforcement, size of firm and causative agents) and the measured factors by using logistic regression model from the computer package program, SPSS version 6.1. 
RESULTS
Most of the sample (70%) were male. Age ranged between 24-72 years (Mean = 48.9, SD = 11.6). The leading occupations were car component and assembly workers (16%), healthcare workers, woodworkers and foundry workers (Table 1) . Three-quarters were still working after the 'COSHH' introduction. Thirty-three per cent worked in small companies (< 50 employees). Nearly half were exposed to one of the substances which are listed as the original seven prescribed agents ( Table 2 ). The causative agents are shown in Table 3 . The most common agents were isocyanates (21%), colophony (8%) and wood dust (7%). Nearly half of the patients (49%) had occupational health service at their workplace. However, less than one-third of the workers had a pre-employment screening, which included history taking (28%) and breathing tests (31%). During the job, only 31% had a regular enquiry about their chest symptoms and 19% had regular breathing tests. Table 4 shows the comparison of the provision of health surveillance between three factors; the time of Regulations enforcement (before 'COSHH', after 'COSHH' but before 'MS25', and after 'MS25'), size of firm, and causative agents. The patients who worked after 'COSHH' introduction, or worked in the larger firms, or were exposed to one of the original seven prescribed agents had a tendency to be provided with health surveillance more than the others. The patients who worked after 'COSHH' but before 'MS25' also had a tendency to be provided with health surveillance more than the ones who worked before 'COSHH' or after both 'COSHH' and 'MS25'. However, the differences only reached statistical significance for pre-employment and routine surveillance lung function in the group exposed to the original seven prescribed agents.
Only 9% of the patients had been informed about the risk of getting asthma at their workplaces (Table  5 ) and no worker who had been employed before the Regulations introduction had been informed about the risk. Nearly three-quarters had never been provided with the safety data sheet. The workers who worked after the 'COSHH' enforcement had seen the data sheet six times more than the ones who worked before hand (p < 0.05). On the contrary, the employers with larger firms provided the data sheet to their employees less than the ones of smaller size.
Only 45% of the workers used personal protective equipment at work. Nearly half of this group (48.9%) used them regularly. The rest used them often (22.2%), sometimes (17.8%) and rarely (11.1%). The types of respiratory personal protective equipment which they used at work included gauze masks (33.3%), disposable respirators (20%), power visor respirators (11.1%) or more than one type (24.4%). In spite of PPE provision, few workplaces provided instruction and training about how to use personal protective equipment ( Table 4) .
DISCUSSION
Occupational asthma is a preventable disease and is related to exposure at the time of disease onset. There is no evidence that occupational asthma in general is becoming less common although there have been some notable successes in specific workplaces. Welldesigned systems, exposure limitation, protective equipment and health surveillance were important in reducing the risk due to biological detergents and laboratory animals. 12 ' 13 The hazard of isocyanates was identified by health surveillance in one factory, and the risk eliminated by substitution.
14 There is a need for more general introduction of these methods, which form the basis of 'COSHH' and 'MS25'.
There are few previous studies investigating the implementation of guidelines for the prevention of occupational asthma. Palmer and Freegard studied hairdressers where the major hazard is dermatitis. 10 They found that few employers were aware of the principles and statutory requirements of the COSHH Regulations such as lack of health care facilities, lack of provision of health care training and health monitoring. Smedley and Coggon studied occupational health services for healthcare workers. 15 They found that most occupational health departments had provided respiratory surveillance for the workers but the process and the exclusion criteria applied as a result of screening varied. The study showed that 93% of the departments offered surveillance for workers exposed to glutaraldehyde, an agent not on the original list of seven prescribed agents. However, nearly 10% did not recognized exposure to glutaraldehyde, which is likely to be present in all hospitals. Eighty-seven provided periodic surveillance with some form of questionnaires, only 31% performed surveillance spirometry. There was no data on the inclusion of individual workers for surveillance.
Our result are at variance with the less formal review of the implementation of COSHH by the Health and Safety Executive who found that 80% of employers were thought to have provided their employees with adequate information and training about the nature of the substances they worked with and about action they should take in emergencies. 9 For routine precautions, and for the correct use of protective equipment, the figure was around 90%. The study also showed that surveillance was not taking place in 36% of the workplaces where there was exposure to high risk agents and the quality of health surveillance regimens varied considerably. Large firms were more likely to have high standards, but there were misunderstandings and differing opinions on all sides about which types of work required health surveillance and the form surveillance should take in particular cases.
These reports suggest that surveillance is taking place more frequently than reported by the workers in our study. This may be due to the development of occupational asthma in those indirectly exposed and not included in surveillance, a partial problem with colophony. 16 Alternatively the better occupational health services in larger firms may have been overrepresented.
The study has its limitations. The sample was only the workers who had occupational asthma and are therefore the failures of disease prevention. Therefore, the study cannot represent all workplaces. All data were obtained from retrospective questionnaires. Recall memory and individual attitude may be a major bias of the study. However, we can conclude that the population of our study lacked health surveillance, hazard education and training by their employers. There were only modest improvements after the introduction of COSHH. The larger firms were better in terms of providing surveillance but less good at providing hazard information than the smaller firms. COSHH implementation was greater in the workplaces where exposure was to a high risk agent.
Finally, we recommend that employers and relevant organizations should increase awareness of occupational asthma in the workplace. Employers have to provide more preventive measures to their workers. Further study of assessing Regulations compliance is need.
